X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA PFIZER ELDER PHARMA/
PFIZER
 
P/E (TTM) x -0.2 35.1 - View Chart
P/BV x 0.1 5.7 1.8% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ELDER PHARMA   PFIZER
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
PFIZER
Mar-17
ELDER PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3802,055 18.5%   
Low Rs1881,651 11.4%   
Sales per share (Unadj.) Rs491.2429.8 114.3%  
Earnings per share (Unadj.) Rs-3.273.6 -4.3%  
Cash flow per share (Unadj.) Rs14.487.4 16.5%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs376.5528.7 71.2%  
Shares outstanding (eoy) m20.5445.75 44.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.64.3 13.4%   
Avg P/E ratio x-89.325.2 -354.6%  
P/CF ratio (eoy) x19.721.2 92.9%  
Price / Book Value ratio x0.83.5 21.5%  
Dividend payout %027.2 0.0%   
Avg Mkt Cap Rs m5,83384,777 6.9%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2,1793,039 71.7%   
Avg. sales/employee Rs ThNM6,925.9-  
Avg. wages/employee Rs ThNM1,070.4-  
Avg. net profit/employee Rs ThNM1,186.3-  
INCOME DATA
Net Sales Rs m10,08919,663 51.3%  
Other income Rs m2571,012 25.4%   
Total revenues Rs m10,34620,674 50.0%   
Gross profit Rs m-7923,491 -22.7%  
Depreciation Rs m361629 57.4%   
Interest Rs m2,75610 28,711.5%   
Profit before tax Rs m-3,6533,864 -94.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7131,304 284.6%   
Tax Rs m1251,801 7.0%   
Profit after tax Rs m-653,368 -1.9%  
Gross profit margin %-7.817.8 -44.2%  
Effective tax rate %-3.446.6 -7.4%   
Net profit margin %-0.617.1 -3.8%  
BALANCE SHEET DATA
Current assets Rs m9,24020,789 44.4%   
Current liabilities Rs m9,9987,870 127.0%   
Net working cap to sales %-7.565.7 -11.4%  
Current ratio x0.92.6 35.0%  
Inventory Days Days4660 77.5%  
Debtors Days Days6022 267.3%  
Net fixed assets Rs m10,1249,175 110.3%   
Share capital Rs m206458 45.0%   
"Free" reserves Rs m5,58223,731 23.5%   
Net worth Rs m7,73424,189 32.0%   
Long term debt Rs m4,88925 19,556.0%   
Total assets Rs m22,88232,706 70.0%  
Interest coverage x-0.3403.5 -0.1%   
Debt to equity ratio x0.60 61,167.2%  
Sales to assets ratio x0.40.6 73.3%   
Return on assets %11.810.3 113.9%  
Return on equity %-0.813.9 -6.1%  
Return on capital %22.321.4 104.3%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30763 487.4%   
Fx outflow Rs m1254,067 3.1%   
Net fx Rs m181-4,004 -4.5%   
CASH FLOW
From Operations Rs m11,7543,288 357.5%  
From Investments Rs m-561-2,496 22.5%  
From Financial Activity Rs m-6,762-826 818.7%  
Net Cashflow Rs m4,432-35 -12,808.4%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 7.5 7.5 100.0%  
FIIs % 16.8 4.9 342.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 23.7 152.3%  
Shareholders   16,479 85,207 19.3%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   GLENMARK PHARMA  FULFORD INDIA  MERCK LTD  BIOCON LTD  UNICHEM LAB  

Compare ELDER PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets End Lower; Metal Stocks Top Losers(Closing)

Indian share markets settled lower today led by a fall in the financial stocks after the rupee hit a record low of 70.32 per dollar.

Related Views on News

PFIZER at All Time High; BSE HEALTHCARE Index Up 0.9% (Market Updates)

Aug 16, 2018 | Updated on Aug 16, 2018

PFIZER share price has hit an all time high at Rs 3,056 (up 4.6%). The BSE HEALTHCARE Index is up by 0.9%. Among the top gainers in the BSE HEALTHCARE Index today are PFIZER (up 4.6%) and ABBOTT INDIA (up 0.2%). The top losers include NATCO PHARMA (down 0.1%) and CAPLIN POINT (down 0.1%).

PFIZER at All Time High; BSE HEALTHCARE Index Up 1.1% (Market Updates)

Aug 16, 2018 | Updated on Aug 16, 2018

PFIZER share price has hit an all time high at Rs 3,018 (up 4.0%). The BSE HEALTHCARE Index is up by 1.1%. Among the top gainers in the BSE HEALTHCARE Index today are PFIZER (up 4.0%) and SANOFI INDIA (up 0.8%). The top losers include ALKEM LABORATORIES (down 0.1%) and ABBOTT INDIA (down 0.2%).

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - SUN PHARMA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS